BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2157059)

  • 1. A mutant poliovirus containing a novel proteolytic cleavage site in VP3 is altered in viral maturation.
    Blair WS; Hwang SS; Ypma-Wong MF; Semler BL
    J Virol; 1990 Apr; 64(4):1784-93. PubMed ID: 2157059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase.
    Blair WS; Semler BL
    J Virol; 1991 Nov; 65(11):6111-23. PubMed ID: 1656088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
    Ansardi DC; Morrow CD
    J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.
    Ansardi DC; Morrow CD
    J Virol; 1995 Mar; 69(3):1540-7. PubMed ID: 7853487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
    Ansardi DC; Luo M; Morrow CD
    Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1991 Apr; 65(4):2088-92. PubMed ID: 1848318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cellular cofactor facilitates efficient 3CD cleavage of the poliovirus P1 precursor.
    Blair WS; Li X; Semler BL
    J Virol; 1993 Apr; 67(4):2336-43. PubMed ID: 8383245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature-sensitive poliovirus mutant fails to cleave VP0 and accumulates provirions.
    Compton SR; Nelsen B; Kirkegaard K
    J Virol; 1990 Sep; 64(9):4067-75. PubMed ID: 2166805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
    Bräutigam S; Snezhkov E; Bishop DH
    Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalysis of poliovirus VP0 maturation cleavage is not mediated by serine 10 of VP2.
    Harber JJ; Bradley J; Anderson CW; Wimmer E
    J Virol; 1991 Jan; 65(1):326-34. PubMed ID: 1845893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a short, highly conserved, motif required for picornavirus capsid precursor processing at distal sites.
    Kristensen T; Belsham GJ
    PLoS Pathog; 2019 Jan; 15(1):e1007509. PubMed ID: 30657784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.
    Porter DC; Ansardi DC; Morrow CD
    J Virol; 1995 Mar; 69(3):1548-55. PubMed ID: 7853488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional poliovirus mutants made by random deletion mutagenesis of infectious cDNA.
    Kirkegaard K; Nelsen B
    J Virol; 1990 Jan; 64(1):185-94. PubMed ID: 2152811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins.
    Ypma-Wong MF; Semler BL
    J Virol; 1987 Oct; 61(10):3181-9. PubMed ID: 3041039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4.
    Hindiyeh M; Li QH; Basavappa R; Hogle JM; Chow M
    J Virol; 1999 Nov; 73(11):9072-9. PubMed ID: 10516013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural domains of the poliovirus polyprotein are major determinants for proteolytic cleavage at Gln-Gly pairs.
    Ypma-Wong MF; Filman DJ; Hogle JM; Semler BL
    J Biol Chem; 1988 Nov; 263(33):17846-56. PubMed ID: 2846581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage sites within the poliovirus capsid protein precursors.
    Larsen GR; Anderson CW; Dorner AJ; Semler BL; Wimmer E
    J Virol; 1982 Jan; 41(1):340-4. PubMed ID: 6283126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.
    Marc D; Masson G; Girard M; van der Werf S
    J Virol; 1990 Sep; 64(9):4099-107. PubMed ID: 2166807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folding and processing of the capsid protein precursor P1 is kinetically retarded in neutralization site 3B mutants of poliovirus.
    Reynolds C; Birnby D; Chow M
    J Virol; 1992 Mar; 66(3):1641-8. PubMed ID: 1310770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.